These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 81224

  • 1. Cellular immunity in infectious mononucleosis. II. Specific reactivity to Epstein-Barr Virus antigens and correlation with clinical and hematologic parameters.
    Nikoskelainen J, Ablashi DV, Isenberg RA, Neel EU, Miller RG, Stevens DA.
    J Immunol; 1978 Oct; 121(4):1239-44. PubMed ID: 81224
    [Abstract] [Full Text] [Related]

  • 2. Epstein Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis.
    Borysiewicz LK, Haworth SJ, Cohen J, Mundin J, Rickinson A, Sissons JG.
    Q J Med; 1986 Feb; 58(226):111-21. PubMed ID: 3012622
    [Abstract] [Full Text] [Related]

  • 3. Demonstration of EBNA (Epstein-Barr virus nuclear antigen) antibodies of different immunoglobulin classes.
    Czeglédy J, Gergely L, Váczi L, Szalka A.
    Acta Microbiol Acad Sci Hung; 1978 Feb; 25(4):237-43. PubMed ID: 224651
    [Abstract] [Full Text] [Related]

  • 4. Prolonged illness after infectious mononucleosis is associated with altered immunity but not with increased viral load.
    Cameron B, Bharadwaj M, Burrows J, Fazou C, Wakefield D, Hickie I, Ffrench R, Khanna R, Lloyd A, Dubbo Infection Outcomes Study.
    J Infect Dis; 2006 Mar 01; 193(5):664-71. PubMed ID: 16453261
    [Abstract] [Full Text] [Related]

  • 5. [Virological and immunological studies on inapparent Epstein-Barr virus infection in healthy individuals: in comparison to immunosuppressed patients and patients with infectious mononucleosis].
    Imai S.
    Hokkaido Igaku Zasshi; 1990 Sep 01; 65(5):481-92. PubMed ID: 2172132
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The significance of serum IgM IgA and IgG antibodies specific for Epstein-Barr virus as determined by immunoperoxidase assay in the rapid diagnosis of infectious mononucleosis.
    Hadar T, Margalith M, Sagiv E, Sarov B, Sarov I.
    Isr J Med Sci; 1995 May 01; 31(5):280-3. PubMed ID: 7759222
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Appearance and some unusual features of Epstein-Barr virus antibody production in infectious mononucleosis and other health disorders.
    Stancek D, Kotuliaková M, Hrúzik J.
    Acta Virol; 1977 Jan 01; 21(1):45-56. PubMed ID: 15437
    [Abstract] [Full Text] [Related]

  • 10. Contribution to rapid diagnosis of infectious mononucleosis.
    Franková V, Stanková M, Kouba K, Hásková V, Pavlík E.
    Acta Virol; 1986 May 01; 30(3):234-42. PubMed ID: 2874728
    [Abstract] [Full Text] [Related]

  • 11. [Antibody formation against specific Epstein-Barr virus antigens in infectious mononucleosis with tonsillectomy in the acute phase of the disease].
    Sauerbrei A, Sprössig M, Wutzler P, Färber I, Schweizer H, Swoboda R, Wilke J.
    Laryngol Rhinol Otol (Stuttg); 1983 Apr 01; 62(4):170-4. PubMed ID: 6191167
    [Abstract] [Full Text] [Related]

  • 12. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined membrane antigens. I. Reactivity in sera from normal persons and from patients with acute infectious mononucleosis.
    Jondal M.
    Clin Exp Immunol; 1976 Jul 01; 25(1):1-5. PubMed ID: 186222
    [Abstract] [Full Text] [Related]

  • 13. Humoral immune response in Epstein-Barr virus infections. I. Elevated serum concentration of the IgG1 subclass in infectious mononucleosis and nasopharyngeal carcinoma.
    Kaschka WP, Hilgers R, Skvaril F.
    Clin Exp Immunol; 1982 Jul 01; 49(1):149-56. PubMed ID: 6290114
    [Abstract] [Full Text] [Related]

  • 14. [Epstein-Barr virus and infectious mononucleosis. A clinical study of Epstein-Barr antibodies (author's transl)].
    Seigneurin JM, Kressmann MC, Lavoué MF, Saez G, Lenoir G.
    Nouv Presse Med; 1978 Dec 09; 7(44):4005-10. PubMed ID: 215969
    [Abstract] [Full Text] [Related]

  • 15. Cellular immune defects to Epstein-Barr virus-determined antigens in young males.
    Masucci MG, Szigeti R, Ernberg I, Masucci G, Klein G, Chessels J, Sieff C, Lie S, Glomstein A, Businco L, Henle W, Henle G, Pearson G, Sakamoto K, Purtilo DT.
    Cancer Res; 1981 Nov 09; 41(11 Pt 1):4284-91. PubMed ID: 6171337
    [Abstract] [Full Text] [Related]

  • 16. Cells containing Epstein--Barr nuclear antigen (EBNA) in peripheral blood.
    Gergely L, Czeglédy J, Váczi L, Szalka A, Berényi E.
    Acta Microbiol Acad Sci Hung; 1979 Nov 09; 26(1):41-5. PubMed ID: 225932
    [Abstract] [Full Text] [Related]

  • 17. Regulatory T cell activity in primary and persistent Epstein-Barr virus infection.
    Wingate PJ, McAulay KA, Anthony IC, Crawford DH.
    J Med Virol; 2009 May 09; 81(5):870-7. PubMed ID: 19319950
    [Abstract] [Full Text] [Related]

  • 18. Cell-mediated immunity to Epstein-Barr-virus-transformed lymphoblastoid cells in acute infectious mononucleosis.
    Royston I, Sullivan JL, Periman PO, Perlin E.
    N Engl J Med; 1975 Dec 04; 293(23):1159-63. PubMed ID: 171568
    [Abstract] [Full Text] [Related]

  • 19. Clinical and immunological considerations in Epstein-Barr virus-associated diseases.
    Andersson J.
    Scand J Infect Dis Suppl; 1996 Dec 04; 100():72-82. PubMed ID: 8860357
    [Abstract] [Full Text] [Related]

  • 20. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells.
    Wasik M, Myc A, Matej H, Rudzka L.
    Arch Immunol Ther Exp (Warsz); 1983 Dec 04; 31(6):871-8. PubMed ID: 6331340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.